Last 12 months
Inside the activity.
6 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 6 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 25, 2023 Filed Apr 26, 2023 20:11 UTC | GrantCommon Stock | 68 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-23-000024 · wf-form4_168253987141606.xml · nonDerivative · entry 1 Newberry Darren C · CIK 0001721939 · SVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,068 F1 · shares: Reflects (i) 24 shares of common stock earned as a result of the Compensation Committee's certification to the achievement of the year two performance goal under the terms of performance stock unit ("PSU") awards granted on May 3, 2021; and (ii) 44 shares of common stock earned as a result of the Compensation Committee's certification to the achievement of the year one performance goal under the terms of PSU awards granted on May 2, 2022. The shares will vest at the end of the three-year terms of the awards. Read SEC document |
|
| April 25, 2023 Filed Apr 26, 2023 20:11 UTC |
Nash William DDirector · President & CEO
|
GrantCommon Stock | 561 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-23-000023 · wf-form4_168253985117306.xml · nonDerivative · entry 1 Nash William D · CIK 0001545342 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,689 F1 · shares: Reflects (i) 195 shares of common stock earned as a result of the Compensation Committee's certification to the achievement of the year two performance goal under the terms of performance stock unit ("PSU") awards granted on May 3, 2021; and (ii) 366 shares of common stock earned as a result of the Compensation Committee's certification to the achievement of the year one performance goal under the terms of PSU awards granted on May 2, 2022. The shares will vest at the end of the three-year terms of the awards. Read SEC document |
| April 25, 2023 Filed Apr 26, 2023 20:10 UTC |
Mayor-Mora Enrique NEVP & CFO
|
GrantCommon Stock | 85 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-23-000022 · wf-form4_168253983536322.xml · nonDerivative · entry 1 Mayor-Mora Enrique N · CIK 0001793012 · EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,401 F1 · shares: Reflects (i) 32 shares of common stock earned as a result of the Compensation Committee's certification to the achievement of the year two performance goal under the terms of performance stock unit ("PSU") awards granted on May 3, 2021; and (ii) 53 shares of common stock earned as a result of the Compensation Committee's certification to the achievement of the year one performance goal under the terms of PSU awards granted on May 2, 2022. The shares will vest at the end of the three-year terms of the awards. Read SEC document |
| April 25, 2023 Filed Apr 26, 2023 20:10 UTC |
Daniels Jon GSVP, CAF
|
GrantCommon Stock | 73 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-23-000020 · wf-form4_168253979745230.xml · nonDerivative · entry 1 Daniels Jon G · CIK 0001628337 · SVP, CAF 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,217 F1 · shares: Reflects (i) 29 shares of common stock earned as a result of the Compensation Committee's certification to the achievement of the year two performance goal under the terms of performance stock unit ("PSU") awards granted on May 3, 2021; and (ii) 44 shares of common stock earned as a result of the Compensation Committee's certification to the achievement of the year one performance goal under the terms of PSU awards granted on May 2, 2022. The shares will vest at the end of the three-year terms of the awards. Read SEC document |
| April 25, 2023 Filed Apr 26, 2023 20:10 UTC |
Lyski JamesEVP & Chief Marketing Officer
|
GrantCommon Stock | 106 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-23-000021 · wf-form4_168253981464419.xml · nonDerivative · entry 1 Lyski James · CIK 0001376853 · EVP & Chief Marketing Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,321 F1 · shares: Reflects (i) 42 shares of common stock earned as a result of the Compensation Committee's certification to the achievement of the year two performance goal under the terms of performance stock unit ("PSU") awards granted on May 3, 2021; and (ii) 64 shares of common stock earned as a result of the Compensation Committee's certification to the achievement of the year one performance goal under the terms of PSU awards granted on May 2, 2022. The shares will vest at the end of the three-year terms of the awards. Read SEC document |
| April 25, 2023 Filed Apr 26, 2023 20:09 UTC |
Cafritz Diane LEVP, General Counsel & CHRO
|
GrantCommon Stock | 85 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-23-000019 · wf-form4_168253977859660.xml · nonDerivative · entry 1 Cafritz Diane L · CIK 0001702741 · EVP, General Counsel & CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,073 F1 · shares: Reflects (i) 32 shares of common stock earned as a result of the Compensation Committee's certification to the achievement of the year two performance goal under the terms of performance stock unit ("PSU") awards granted on May 3, 2021; and (ii) 53 shares of common stock earned as a result of the Compensation Committee's certification to the achievement of the year one performance goal under the terms of PSU awards granted on May 2, 2022. The shares will vest at the end of the three-year terms of the awards. Read SEC document |
| December 30, 2022 Filed Jan 3, 2023 21:41 UTC |
Nash William DDirector · President & CEO
|
PurchaseCommon Stock | 8,220 | $60.98 | $501,255.60 |
DisclosureSEC source: 0001170010-23-000002 · wf-form4_167278203317587.xml · nonDerivative · entry 1 Nash William D · CIK 0001545342 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,128 F1 · price: The price reported is the weighted average price. The shares were purchased in multiple transactions at prices ranging from $60.70 to $61.12. Upon request, the Reporting Person will provide the Securities and Exchange Commission staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| December 28, 2022 Filed Dec 30, 2022 21:17 UTC |
Wilson Charles JosephEVP and COO
|
GrantStock Options (Right to Buy) · Derivative | 2,509 | $0.00 Strike: $59.24 | $0.00 |
DisclosureSEC source: 0001170010-22-000108 · wf-form4_167243506046480.xml · derivative · entry 2 Wilson Charles Joseph · CIK 0001721932 · EVP and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,509 Underlying: Common Stock · 2,509 shares Expires 2029-12-28 F3 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F4 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of December 28, 2023, December 28, 2024, December 28, 2025, and December 28, 2026. Read SEC document |
| December 28, 2022 Filed Dec 30, 2022 21:17 UTC |
Wilson Charles JosephEVP and COO
|
GrantRestricted Stock Units · Derivative | 251 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-22-000108 · wf-form4_167243506046480.xml · derivative · entry 1 Wilson Charles Joseph · CIK 0001721932 · EVP and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251 Underlying: Common Stock · Not disclosed shares Expires not disclosed F1 · derivative.exercise_price: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.55 to the Company's Annual Report on Form 10-K filed on April 21, 2020. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. F2 · derivative.exercise_date: The restricted stock units shall vest on December 28, 2025. F1 · derivative.expiration_date: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.55 to the Company's Annual Report on Form 10-K filed on April 21, 2020. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. F2 · derivative.expiration_date: The restricted stock units shall vest on December 28, 2025. F1 · derivative.underlying_shares: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.55 to the Company's Annual Report on Form 10-K filed on April 21, 2020. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. Read SEC document |
| December 26, 2022 Filed Dec 28, 2022 21:30 UTC |
Mayor-Mora Enrique NEVP & CFO
|
Exercise / conversionRestricted Stock Units · Derivative | 447 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-22-000106 · wf-form4_167226300676753.xml · derivative · entry 3 Mayor-Mora Enrique N · CIK 0001793012 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 331 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), the Reporting Person received 0.7411 times the number of MSUs in shares of Company common stock. F2 · derivative.exercise_date: The restricted stock units vested on December 26, 2022 and were settled in Company common stock. F2 · derivative.expiration_date: The restricted stock units vested on December 26, 2022 and were settled in Company common stock. Read SEC document |
| December 26, 2022 Filed Dec 28, 2022 21:30 UTC |
Mayor-Mora Enrique NEVP & CFO
|
Tax withholdingCommon Stock | 150 | $60.16 | $9,024.00 |
DisclosureSEC source: 0001170010-22-000106 · wf-form4_167226300676753.xml · nonDerivative · entry 2 Mayor-Mora Enrique N · CIK 0001793012 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,316 Read SEC document |
| December 26, 2022 Filed Dec 28, 2022 21:30 UTC |
Mayor-Mora Enrique NEVP & CFO
|
Exercise / conversionCommon Stock | 331 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001170010-22-000106 · wf-form4_167226300676753.xml · nonDerivative · entry 1 Mayor-Mora Enrique N · CIK 0001793012 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,466 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), the Reporting Person received 0.7411 times the number of MSUs in shares of Company common stock. Read SEC document |
| December 26, 2022 Filed Dec 28, 2022 21:30 UTC |
Livesay Jill AVP, Controller & PAO
|
Tax withholdingCommon Stock | 1,020 | $60.16 | $61,363.20 |
DisclosureSEC source: 0001170010-22-000105 · wf-form4_167226298956622.xml · nonDerivative · entry 1 Livesay Jill A · CIK 0001456533 · VP, Controller & PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,986 Read SEC document |
| July 21, 2022 Filed Jul 22, 2022 20:16 UTC |
Cafritz Diane LEVP, General Counsel & CHRO
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 15,555 | $0.00 Strike: $58.38 | $0.00 |
DisclosureSEC source: 0001170010-22-000093 · wf-form4_165852095453954.xml · derivative · entry 3 Cafritz Diane L · CIK 0001702741 · EVP, General Counsel & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,555 shares Expires 2024-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options became exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2018, May 1, 2019, May 1, 2020 and May 1, 2021 and are now fully exercisable. Read SEC document |
| July 21, 2022 Filed Jul 22, 2022 20:16 UTC |
Cafritz Diane LEVP, General Counsel & CHRO
|
SaleCommon Stock | 15,555 | $94.75 | $1,473,836.25 |
DisclosureSEC source: 0001170010-22-000093 · wf-form4_165852095453954.xml · nonDerivative · entry 2 Cafritz Diane L · CIK 0001702741 · EVP, General Counsel & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,988 Read SEC document |
| July 21, 2022 Filed Jul 22, 2022 20:16 UTC |
Cafritz Diane LEVP, General Counsel & CHRO
|
Exercise / conversionCommon Stock | 15,555 | $58.38 | $908,100.90 |
DisclosureSEC source: 0001170010-22-000093 · wf-form4_165852095453954.xml · nonDerivative · entry 1 Cafritz Diane L · CIK 0001702741 · EVP, General Counsel & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,543 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 18, 2022 Filed Jul 19, 2022 20:20 UTC |
Shamim MohammadEVP and CITO
|
SaleCommon Stock | 3,456 | $93.91 | $324,552.96 |
DisclosureSEC source: 0001170010-22-000091 · wf-form4_165826200472583.xml · nonDerivative · entry 1 Shamim Mohammad · CIK 0001620490 · EVP and CITO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,769 F1 · price: The shares with respect to this transaction were sold at prices ranging from $93.50 to $94.22. Upon request, the Reporting Person will provide the Securities and Exchange Commission staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 01, 2022 Filed Jul 5, 2022 20:28 UTC |
STEENROD MITCHELL DDirector
|
GrantCommon Stock | 1,996 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-22-000089 · wf-form4_165705291430609.xml · nonDerivative · entry 1 STEENROD MITCHELL D · CIK 0001511361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,469 Read SEC document |
| July 01, 2022 Filed Jul 5, 2022 20:28 UTC |
Shinder MarcellaDirector
|
GrantCommon Stock | 1,996 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-22-000088 · wf-form4_165705287703654.xml · nonDerivative · entry 1 Shinder Marcella · CIK 0001639923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,858 Read SEC document |
| July 01, 2022 Filed Jul 5, 2022 20:27 UTC |
Satriano PietroDirector
|
GrantCommon Stock | 1,996 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-22-000087 · wf-form4_165705285261377.xml · nonDerivative · entry 1 Satriano Pietro · CIK 0001675303 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,754 Read SEC document |
| July 01, 2022 Filed Jul 5, 2022 20:27 UTC |
ONeil Mark FDirector
|
GrantCommon Stock | 1,996 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-22-000086 · wf-form4_165705281343876.xml · nonDerivative · entry 1 ONeil Mark F · CIK 0001342016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,313 Read SEC document |
| July 01, 2022 Filed Jul 5, 2022 20:26 UTC |
Goodman ShiraDirector
|
GrantCommon Stock | 1,996 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-22-000084 · wf-form4_165705274160277.xml · nonDerivative · entry 1 Goodman Shira · CIK 0001199915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,764 Read SEC document |
| July 01, 2022 Filed Jul 5, 2022 20:26 UTC |
McCreight David W.Director
|
GrantCommon Stock | 1,996 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-22-000085 · wf-form4_165705278444173.xml · nonDerivative · entry 1 McCreight David W. · CIK 0001440360 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,138 Read SEC document |
| July 01, 2022 Filed Jul 5, 2022 20:25 UTC |
FOLLIARD THOMAS JDirector
|
GrantCommon Stock | 1,996 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-22-000083 · wf-form4_165705272337141.xml · nonDerivative · entry 1 FOLLIARD THOMAS J · CIK 0001223841 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,260 Read SEC document |
| July 01, 2022 Filed Jul 5, 2022 20:24 UTC |
BLAYLOCK RONALD EDirector
|
GrantCommon Stock | 1,996 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-22-000081 · wf-form4_165705263740252.xml · nonDerivative · entry 1 BLAYLOCK RONALD E · CIK 0001214686 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,850 Read SEC document |
| July 01, 2022 Filed Jul 5, 2022 20:25 UTC |
Chawla SonaDirector
|
GrantCommon Stock | 1,996 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-22-000082 · wf-form4_165705268344471.xml · nonDerivative · entry 1 Chawla Sona · CIK 0001438864 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,141 Read SEC document |
| July 01, 2022 Filed Jul 5, 2022 20:23 UTC |
Bensen Peter JDirector
|
GrantCommon Stock | 1,996 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-22-000080 · wf-form4_165705258619860.xml · nonDerivative · entry 1 Bensen Peter J · CIK 0001395526 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,735 Read SEC document |
| July 01, 2022 Filed Jul 5, 2022 20:17 UTC |
Cafritz Diane LEVP, General Counsel & CHRO
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $58.38 | $0.00 |
DisclosureSEC source: 0001170010-22-000069 · wf-form4_165705222564566.xml · derivative · entry 4 Cafritz Diane L · CIK 0001702741 · EVP, General Counsel & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,555 Underlying: Common Stock · 15,000 shares Expires 2024-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options became exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2018, May 1, 2019, May 1, 2020 and May 1, 2021 and are now fully exercisable. Read SEC document |
| July 01, 2022 Filed Jul 5, 2022 20:17 UTC |
Cafritz Diane LEVP, General Counsel & CHRO
|
SaleCommon Stock | 3,092 | $90.76 | $280,629.92 |
DisclosureSEC source: 0001170010-22-000069 · wf-form4_165705222564566.xml · nonDerivative · entry 3 Cafritz Diane L · CIK 0001702741 · EVP, General Counsel & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,988 Read SEC document |
| July 01, 2022 Filed Jul 5, 2022 20:17 UTC |
Cafritz Diane LEVP, General Counsel & CHRO
|
SaleCommon Stock | 15,000 | $91.12 | $1,366,800.00 |
DisclosureSEC source: 0001170010-22-000069 · wf-form4_165705222564566.xml · nonDerivative · entry 2 Cafritz Diane L · CIK 0001702741 · EVP, General Counsel & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,080 F1 · price: The shares with respect to this transaction were sold at prices ranging from $90.70 to $91.60. Upon request, the Reporting Person will provide the Securities and Exchange Commission staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 01, 2022 Filed Jul 5, 2022 20:17 UTC |
Cafritz Diane LEVP, General Counsel & CHRO
|
Exercise / conversionCommon Stock | 15,000 | $58.38 | $875,700.00 |
DisclosureSEC source: 0001170010-22-000069 · wf-form4_165705222564566.xml · nonDerivative · entry 1 Cafritz Diane L · CIK 0001702741 · EVP, General Counsel & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 02, 2022 Filed May 3, 2022 22:27 UTC | GrantStock Options (Right to Buy) · Derivative | 26,866 | $0.00 Strike: $91.14 | $0.00 |
DisclosureSEC source: 0001170010-22-000051 · wf-form4_165161678473249.xml · derivative · entry 2 Wilson Charles Joseph · CIK 0001721932 · SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,866 Underlying: Common Stock · 26,866 shares Expires 2029-05-02 F1 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F2 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 2, 2023, May 2, 2024, May 2, 2025 and May 2, 2026. Read SEC document |
|
| May 02, 2022 Filed May 3, 2022 22:26 UTC |
Shamim MohammadEVP and CITO
|
GrantStock Options (Right to Buy) · Derivative | 32,561 | $0.00 Strike: $91.14 | $0.00 |
DisclosureSEC source: 0001170010-22-000050 · wf-form4_165161674197301.xml · derivative · entry 2 Shamim Mohammad · CIK 0001620490 · EVP and CITO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,561 Underlying: Common Stock · 32,561 shares Expires 2029-05-02 F1 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F2 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 2, 2023, May 2, 2024, May 2, 2025 and May 2, 2026. Read SEC document |
| May 02, 2022 Filed May 3, 2022 22:25 UTC | GrantStock Options (Right to Buy) · Derivative | 26,866 | $0.00 Strike: $91.14 | $0.00 |
DisclosureSEC source: 0001170010-22-000049 · wf-form4_165161665054746.xml · derivative · entry 2 Newberry Darren C · CIK 0001721939 · SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,866 Underlying: Common Stock · 26,866 shares Expires 2029-05-02 F1 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F2 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 2, 2023, May 2, 2024, May 2, 2025 and May 2, 2026. Read SEC document |
|
| May 02, 2022 Filed May 3, 2022 22:24 UTC |
Nash William DPresident & CEO
|
GrantStock Options (Right to Buy) · Derivative | 225,090 | $0.00 Strike: $91.14 | $0.00 |
DisclosureSEC source: 0001170010-22-000048 · wf-form4_165161661836661.xml · derivative · entry 2 Nash William D · CIK 0001545342 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,090 Underlying: Common Stock · 225,090 shares Expires 2029-05-02 F1 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F2 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 2, 2023, May 2, 2024, May 2, 2025 and May 2, 2026. Read SEC document |
| May 02, 2022 Filed May 3, 2022 22:23 UTC |
Mayor-Mora Enrique NEVP & CFO
|
GrantStock Options (Right to Buy) · Derivative | 32,561 | $0.00 Strike: $91.14 | $0.00 |
DisclosureSEC source: 0001170010-22-000047 · wf-form4_165161654547994.xml · derivative · entry 4 Mayor-Mora Enrique N · CIK 0001793012 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,561 Underlying: Common Stock · 32,561 shares Expires 2029-05-02 F3 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F4 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 2, 2023, May 2, 2024, May 2, 2025 and May 2, 2026. Read SEC document |
| May 02, 2022 Filed May 3, 2022 22:22 UTC |
Lyski JamesEVP & Chief Marketing Officer
|
GrantStock Options (Right to Buy) · Derivative | 39,193 | $0.00 Strike: $91.14 | $0.00 |
DisclosureSEC source: 0001170010-22-000046 · wf-form4_165161645593596.xml · derivative · entry 2 Lyski James · CIK 0001376853 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,193 Underlying: Common Stock · 39,193 shares Expires 2029-05-02 F1 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F2 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 2, 2023, May 2, 2024, May 2, 2025 and May 2, 2026. Read SEC document |
| May 02, 2022 Filed May 3, 2022 22:20 UTC |
Livesay Jill AVP, Controller & PAO
|
GrantStock Options (Right to Buy) · Derivative | 16,114 | $0.00 Strike: $91.14 | $0.00 |
DisclosureSEC source: 0001170010-22-000045 · wf-form4_165161639483430.xml · derivative · entry 5 Livesay Jill A · CIK 0001456533 · VP, Controller & PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,114 Underlying: Common Stock · 16,114 shares Expires 2029-05-02 F5 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F6 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 2, 2023, May 2, 2024, May 2, 2025 and May 2, 2026. Read SEC document |
| May 02, 2022 Filed May 3, 2022 22:20 UTC |
Livesay Jill AVP, Controller & PAO
|
GrantRestricted Stock Units · Derivative | 1,414 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-22-000045 · wf-form4_165161639483430.xml · derivative · entry 4 Livesay Jill A · CIK 0001456533 · VP, Controller & PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,414 Underlying: Common Stock · Not disclosed shares Expires not disclosed F3 · derivative.exercise_price: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.55 to the Company's Annual Report on Form 10-K filed on April 21, 2020. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. F4 · derivative.exercise_date: The restricted stock units shall vest on May 2, 2025. F3 · derivative.expiration_date: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.55 to the Company's Annual Report on Form 10-K filed on April 21, 2020. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. F4 · derivative.expiration_date: The restricted stock units shall vest on May 2, 2025. F3 · derivative.underlying_shares: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.55 to the Company's Annual Report on Form 10-K filed on April 21, 2020. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. Read SEC document |
| May 02, 2022 Filed May 3, 2022 22:19 UTC |
Daniels Jon GSVP, CAF
|
GrantStock Options (Right to Buy) · Derivative | 26,866 | $0.00 Strike: $91.14 | $0.00 |
DisclosureSEC source: 0001170010-22-000044 · wf-form4_165161629393369.xml · derivative · entry 2 Daniels Jon G · CIK 0001628337 · SVP, CAF 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,866 Underlying: Common Stock · 26,866 shares Expires 2029-05-02 F1 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F2 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 2, 2023, May 2, 2024, May 2, 2025 and May 2, 2026. Read SEC document |
| May 02, 2022 Filed May 3, 2022 22:18 UTC |
Cafritz Diane LEVP, General Counsel & CHRO
|
GrantStock Options (Right to Buy) · Derivative | 32,561 | $0.00 Strike: $91.14 | $0.00 |
DisclosureSEC source: 0001170010-22-000043 · wf-form4_165161622882153.xml · derivative · entry 2 Cafritz Diane L · CIK 0001702741 · EVP, General Counsel & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,561 Underlying: Common Stock · 32,561 shares Expires 2029-05-02 F1 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F2 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 2, 2023, May 2, 2024, May 2, 2025 and May 2, 2026. Read SEC document |
| May 01, 2022 Filed May 3, 2022 22:27 UTC | Tax withholdingCommon Stock | 1,332 | $85.78 | $114,258.96 |
DisclosureSEC source: 0001170010-22-000051 · wf-form4_165161678473249.xml · nonDerivative · entry 1 Wilson Charles Joseph · CIK 0001721932 · SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,985 Read SEC document |
|
| May 01, 2022 Filed May 3, 2022 22:26 UTC |
Shamim MohammadEVP and CITO
|
Tax withholdingCommon Stock | 1,587 | $85.78 | $136,132.86 |
DisclosureSEC source: 0001170010-22-000050 · wf-form4_165161674197301.xml · nonDerivative · entry 1 Shamim Mohammad · CIK 0001620490 · EVP and CITO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,225 Read SEC document |
| May 01, 2022 Filed May 3, 2022 22:25 UTC | Tax withholdingCommon Stock | 1,330 | $85.78 | $114,087.40 |
DisclosureSEC source: 0001170010-22-000049 · wf-form4_165161665054746.xml · nonDerivative · entry 1 Newberry Darren C · CIK 0001721939 · SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Read SEC document |
|
| May 01, 2022 Filed May 3, 2022 22:24 UTC |
Nash William DPresident & CEO
|
Tax withholdingCommon Stock | 12,208 | $85.78 | $1,047,202.24 |
DisclosureSEC source: 0001170010-22-000048 · wf-form4_165161661836661.xml · nonDerivative · entry 1 Nash William D · CIK 0001545342 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,908 Read SEC document |
| May 01, 2022 Filed May 3, 2022 22:23 UTC |
Mayor-Mora Enrique NEVP & CFO
|
Exercise / conversionRestricted Stock Units · Derivative | 1,536 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-22-000047 · wf-form4_165161654547994.xml · derivative · entry 3 Mayor-Mora Enrique N · CIK 0001793012 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,905 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), the Reporting Person received approximately 1.24 times the number of MSUs in shares of Company common stock. F2 · derivative.exercise_date: The restricted stock units vested on May 1, 2022 and were settled in Company common stock. F2 · derivative.expiration_date: The restricted stock units vested on May 1, 2022 and were settled in Company common stock. Read SEC document |
| May 01, 2022 Filed May 3, 2022 22:23 UTC |
Mayor-Mora Enrique NEVP & CFO
|
Tax withholdingCommon Stock | 574 | $85.78 | $49,237.72 |
DisclosureSEC source: 0001170010-22-000047 · wf-form4_165161654547994.xml · nonDerivative · entry 2 Mayor-Mora Enrique N · CIK 0001793012 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,135 Read SEC document |
| May 01, 2022 Filed May 3, 2022 22:23 UTC |
Mayor-Mora Enrique NEVP & CFO
|
Exercise / conversionCommon Stock | 1,905 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001170010-22-000047 · wf-form4_165161654547994.xml · nonDerivative · entry 1 Mayor-Mora Enrique N · CIK 0001793012 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,709 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), the Reporting Person received approximately 1.24 times the number of MSUs in shares of Company common stock. Read SEC document |
| May 01, 2022 Filed May 3, 2022 22:22 UTC |
Lyski JamesEVP & Chief Marketing Officer
|
Tax withholdingCommon Stock | 1,926 | $85.78 | $165,212.28 |
DisclosureSEC source: 0001170010-22-000046 · wf-form4_165161645593596.xml · nonDerivative · entry 1 Lyski James · CIK 0001376853 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,215 Read SEC document |
| May 01, 2022 Filed May 3, 2022 22:20 UTC |
Livesay Jill AVP, Controller & PAO
|
Exercise / conversionRestricted Stock Units · Derivative | 1,632 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-22-000045 · wf-form4_165161639483430.xml · derivative · entry 3 Livesay Jill A · CIK 0001456533 · VP, Controller & PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,024 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), the Reporting Person received approximately 1.24 times the number of MSUs in shares of Company common stock. F2 · derivative.exercise_date: The restricted stock units vested on May 1, 2022 and were settled in Company common stock. F2 · derivative.expiration_date: The restricted stock units vested on May 1, 2022 and were settled in Company common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.